In vivo expressed biologics for infectious disease prophylaxis: rapid delivery of DNA-based antiviral antibodies.
Andrews CD, Huang Y, Ho DD, Liberatore RA.
Emerg Microbes Infect. 2020 Dec;9(1):1523-1533. doi: 10.1080/22221751.2020.1787108.
DNA vaccines: prime time is now.
Gary EN, Weiner DB.
Curr Opin Immunol. 2020 Aug;65:21-27. doi: 10.1016/j.coi.2020.01.006. Epub 2020 Apr 4.
CRISPR-based strategies in infectious disease diagnosis and therapy.
Binnie A, Fernandes E, Almeida-Lousada H, de Mello RA, Castelo-Branco P.
Infection. 2021 Jun;49(3):377-385. doi: 10.1007/s15010-020-01554-w. Epub 2021 Jan 3.
[HIV and pregnancy].
Zweifel VB, Berger C, Nadal D, Grawe C.
Ther Umsch. 2014 Aug;71(8):498-502. doi: 10.1024/0040-5930/a000543.
Emerging vistas in theranostic medicine.
Shetty Y, Prabhu P, Prabhakar B.
Int J Pharm. 2019 Mar 10;558:29-42. doi: 10.1016/j.ijpharm.2018.12.068. Epub 2018 Dec 29.
Advances in the design and delivery of RNA vaccines for infectious diseases.
Lokras AG, Bobak TR, Baghel SS, Sebastiani F, Foged C.
Adv Drug Deliv Rev. 2024 Oct;213:115419. doi: 10.1016/j.addr.2024.115419. Epub 2024 Aug 5.
Antiretroviral Options and Treatment Decisions During Pregnancy.
Poliektov NE, Badell ML.
Paediatr Drugs. 2023 May;25(3):267-282. doi: 10.1007/s40272-023-00559-w. Epub 2023 Feb 2.
Hybrid Nanosystems of Antibiotics with Metal Nanoparticles-Novel Antibacterial Agents.
Shabatina TI, Vernaya OI, Melnikov MY.
Molecules. 2023 Feb 7;28(4):1603. doi: 10.3390/molecules28041603.
Delivery in pregnant women infected with SARS-CoV-2: A fast review.
Parazzini F, Bortolus R, Mauri PA, Favilli A, Gerli S, Ferrazzi E.
Int J Gynaecol Obstet. 2020 Jul;150(1):41-46. doi: 10.1002/ijgo.13166. Epub 2020 May 1.
mRNA: A Novel Avenue to Antibody Therapy?
Schlake T, Thran M, Fiedler K, Heidenreich R, Petsch B, Fotin-Mleczek M.
Mol Ther. 2019 Apr 10;27(4):773-784. doi: 10.1016/j.ymthe.2019.03.002. Epub 2019 Mar 6.
